Taiwan Liposome Company Ltd ADR (TLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -34,978 | -26,861 | -29,426 | -29,454 |
| Depreciation Amortization | 2,000 | 2,387 | 1,550 | 1,772 |
| Accounts receivable | 208 | -193 | -24 | -24 |
| Other Working Capital | 1,667 | -2,046 | 4,148 | -2,354 |
| Other Operating Activity | -64 | 716 | 1,338 | 2,423 |
| Operating Cash Flow | $-31,167 | $-25,997 | $-22,414 | $-27,637 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,146 | -1,806 | -2,179 | -610 |
| Purchase Of Investment | N/A | N/A | -10,034 | N/A |
| Purchase Sale Intangibles | -67 | -150 | -103 | -243 |
| Other Investing Activity | -117 | 10,237 | 167 | -384 |
| Investing Cash Flow | $-1,263 | $8,431 | $-12,046 | $-994 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 1,068 | 2,006 | 2,810 | 3,171 |
| Debt Issued | 21,363 | N/A | 23,900 | N/A |
| Debt Repayment | -13,367 | -1,886 | -11,986 | -57 |
| Common Stock Issued | 24,217 | 27,964 | 18,012 | 169 |
| Other Financing Activity | 10,456 | -3,208 | -2,951 | -3,132 |
| Financing Cash Flow | $43,737 | $24,876 | $29,785 | $151 |
| Exchange Rate Effect | 46 | -75 | -37 | -99 |
| Beginning Cash Position | 36,463 | 26,997 | 31,092 | 60,688 |
| End Cash Position | 47,816 | 34,232 | 26,380 | 32,109 |
| Net Cash Flow | $11,353 | $7,235 | $-4,712 | $-28,579 |
| Free Cash Flow | ||||
| Operating Cash Flow | -31,167 | -25,997 | -22,414 | -27,637 |
| Capital Expenditure | -1,158 | -1,859 | -2,179 | -611 |
| Free Cash Flow | -32,325 | -27,856 | -24,593 | -28,248 |